Page last updated: 2024-11-05

trimethadione and Anti-MuSK Myasthenia Gravis

trimethadione has been researched along with Anti-MuSK Myasthenia Gravis in 4 studies

Trimethadione: An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)
trimethadione : An oxazolidinone that is 1,3-oxazolidine-2,4-dione substituted by methyl groups at positions 3, 5 and 5. It is an antiepileptic agent.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Peterson, H1
Booker, HE2
Chun, RW2
Sanguino, M2
Gilbert, GJ1

Other Studies

4 other studies available for trimethadione and Anti-MuSK Myasthenia Gravis

ArticleYear
Association of trimethadione therapy and myasthenia gravis.
    The New England journal of medicine, 1966, Mar-03, Volume: 274, Issue:9

    Topics: Anticonvulsants; Autoimmune Diseases; Child; Epilepsy, Absence; Female; Humans; Myasthenia Gravis; T

1966
Myasthenic syndrome associated with trimethadione.
    Neurology, 1968, Volume: 18, Issue:3

    Topics: Anticonvulsants; Autoantibodies; Child; Epilepsy, Absence; Female; Humans; Myasthenia Gravis; Oxazol

1968
Myasthenia gravis syndrome associated with trimethadione.
    JAMA, 1970, Jun-29, Volume: 212, Issue:13

    Topics: Anticonvulsants; Autoimmune Diseases; Child; Drug Hypersensitivity; Epilepsy, Absence; Female; Human

1970
Myasthenia gravis and epilepsy.
    The Journal of the Florida Medical Association, 1970, Volume: 57, Issue:5

    Topics: Adult; Anticonvulsants; Epilepsy, Absence; Epilepsy, Tonic-Clonic; Female; Humans; Myasthenia Gravis

1970